RESIN PARTICLE, MEDICAL MATERIAL AND PHARMACEUTICAL PREPARATION CONTAINING SAID RESIN PARTICLE

A resin particle is provided which comprises an ethylene vinyl alcohol copolymer and 5 to 90 percent by weight of cilostazol incorporated therein, and has a particle size of not greater than 2,000 'mu'm. The resin particle, upon being administered orally, allows the concentration of cilost...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HIROAKI YAMAMOTO, SHINSUKE NAKAGAWA, KEIGO YAMADA, RIKA HAMAMOTO, YUZO KIMURA, SEIICHIRO IGUCHI, TOSHIO NAKAMURA, MINORU YAMATO
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HIROAKI YAMAMOTO
SHINSUKE NAKAGAWA
KEIGO YAMADA
RIKA HAMAMOTO
YUZO KIMURA
SEIICHIRO IGUCHI
TOSHIO NAKAMURA
MINORU YAMATO
description A resin particle is provided which comprises an ethylene vinyl alcohol copolymer and 5 to 90 percent by weight of cilostazol incorporated therein, and has a particle size of not greater than 2,000 'mu'm. The resin particle, upon being administered orally, allows the concentration of cilostazol in blood to be kept constant over an extended period of time and, therefore, remarkably alleviates side effects such as pain and headache which may otherwise be caused by rapid release of cilostazol into a body. Se provee una partícula de resina que comprende un copolímero de etileno y alcohol vinílico y de 5 a 90% en peso de cilostazol incorporado en el mismo, y tiene un tamaño de partícula no mayor de 2,000 æm; la partícula de resina, al ser administrada oralmente, permite que la concentracion de cilostazol en sangre se mantenga constante durante un periodo prolongado y por lo tanto alivia notablemente los efectos secundarios tales como cefalgia y fuerte malestar, que pueden ocasionarse de otra manera por la liberacion rápida de cilostazol en el cuerpo.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX9705185A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX9705185A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX9705185A3</originalsourceid><addsrcrecordid>eNrjZIgLcg329FMIcAwK8XT2cdVR8HV18XR29FHwdQxxDfIEMhz9XBQCPByDfB2dXUNDwHIBQa5ADY4hnv5-Cs7-fiGOnn6efu4KwY6eLgqo5vEwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknjfCEtzA1NDC1NHY8IqAEWTMik</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RESIN PARTICLE, MEDICAL MATERIAL AND PHARMACEUTICAL PREPARATION CONTAINING SAID RESIN PARTICLE</title><source>esp@cenet</source><creator>HIROAKI YAMAMOTO ; SHINSUKE NAKAGAWA ; KEIGO YAMADA ; RIKA HAMAMOTO ; YUZO KIMURA ; SEIICHIRO IGUCHI ; TOSHIO NAKAMURA ; MINORU YAMATO</creator><creatorcontrib>HIROAKI YAMAMOTO ; SHINSUKE NAKAGAWA ; KEIGO YAMADA ; RIKA HAMAMOTO ; YUZO KIMURA ; SEIICHIRO IGUCHI ; TOSHIO NAKAMURA ; MINORU YAMATO</creatorcontrib><description>A resin particle is provided which comprises an ethylene vinyl alcohol copolymer and 5 to 90 percent by weight of cilostazol incorporated therein, and has a particle size of not greater than 2,000 'mu'm. The resin particle, upon being administered orally, allows the concentration of cilostazol in blood to be kept constant over an extended period of time and, therefore, remarkably alleviates side effects such as pain and headache which may otherwise be caused by rapid release of cilostazol into a body. Se provee una partícula de resina que comprende un copolímero de etileno y alcohol vinílico y de 5 a 90% en peso de cilostazol incorporado en el mismo, y tiene un tamaño de partícula no mayor de 2,000 æm; la partícula de resina, al ser administrada oralmente, permite que la concentracion de cilostazol en sangre se mantenga constante durante un periodo prolongado y por lo tanto alivia notablemente los efectos secundarios tales como cefalgia y fuerte malestar, que pueden ocasionarse de otra manera por la liberacion rápida de cilostazol en el cuerpo.</description><edition>6</edition><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1997</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19971031&amp;DB=EPODOC&amp;CC=MX&amp;NR=9705185A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19971031&amp;DB=EPODOC&amp;CC=MX&amp;NR=9705185A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HIROAKI YAMAMOTO</creatorcontrib><creatorcontrib>SHINSUKE NAKAGAWA</creatorcontrib><creatorcontrib>KEIGO YAMADA</creatorcontrib><creatorcontrib>RIKA HAMAMOTO</creatorcontrib><creatorcontrib>YUZO KIMURA</creatorcontrib><creatorcontrib>SEIICHIRO IGUCHI</creatorcontrib><creatorcontrib>TOSHIO NAKAMURA</creatorcontrib><creatorcontrib>MINORU YAMATO</creatorcontrib><title>RESIN PARTICLE, MEDICAL MATERIAL AND PHARMACEUTICAL PREPARATION CONTAINING SAID RESIN PARTICLE</title><description>A resin particle is provided which comprises an ethylene vinyl alcohol copolymer and 5 to 90 percent by weight of cilostazol incorporated therein, and has a particle size of not greater than 2,000 'mu'm. The resin particle, upon being administered orally, allows the concentration of cilostazol in blood to be kept constant over an extended period of time and, therefore, remarkably alleviates side effects such as pain and headache which may otherwise be caused by rapid release of cilostazol into a body. Se provee una partícula de resina que comprende un copolímero de etileno y alcohol vinílico y de 5 a 90% en peso de cilostazol incorporado en el mismo, y tiene un tamaño de partícula no mayor de 2,000 æm; la partícula de resina, al ser administrada oralmente, permite que la concentracion de cilostazol en sangre se mantenga constante durante un periodo prolongado y por lo tanto alivia notablemente los efectos secundarios tales como cefalgia y fuerte malestar, que pueden ocasionarse de otra manera por la liberacion rápida de cilostazol en el cuerpo.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1997</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIgLcg329FMIcAwK8XT2cdVR8HV18XR29FHwdQxxDfIEMhz9XBQCPByDfB2dXUNDwHIBQa5ADY4hnv5-Cs7-fiGOnn6efu4KwY6eLgqo5vEwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknjfCEtzA1NDC1NHY8IqAEWTMik</recordid><startdate>19971031</startdate><enddate>19971031</enddate><creator>HIROAKI YAMAMOTO</creator><creator>SHINSUKE NAKAGAWA</creator><creator>KEIGO YAMADA</creator><creator>RIKA HAMAMOTO</creator><creator>YUZO KIMURA</creator><creator>SEIICHIRO IGUCHI</creator><creator>TOSHIO NAKAMURA</creator><creator>MINORU YAMATO</creator><scope>EVB</scope></search><sort><creationdate>19971031</creationdate><title>RESIN PARTICLE, MEDICAL MATERIAL AND PHARMACEUTICAL PREPARATION CONTAINING SAID RESIN PARTICLE</title><author>HIROAKI YAMAMOTO ; SHINSUKE NAKAGAWA ; KEIGO YAMADA ; RIKA HAMAMOTO ; YUZO KIMURA ; SEIICHIRO IGUCHI ; TOSHIO NAKAMURA ; MINORU YAMATO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX9705185A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>1997</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HIROAKI YAMAMOTO</creatorcontrib><creatorcontrib>SHINSUKE NAKAGAWA</creatorcontrib><creatorcontrib>KEIGO YAMADA</creatorcontrib><creatorcontrib>RIKA HAMAMOTO</creatorcontrib><creatorcontrib>YUZO KIMURA</creatorcontrib><creatorcontrib>SEIICHIRO IGUCHI</creatorcontrib><creatorcontrib>TOSHIO NAKAMURA</creatorcontrib><creatorcontrib>MINORU YAMATO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HIROAKI YAMAMOTO</au><au>SHINSUKE NAKAGAWA</au><au>KEIGO YAMADA</au><au>RIKA HAMAMOTO</au><au>YUZO KIMURA</au><au>SEIICHIRO IGUCHI</au><au>TOSHIO NAKAMURA</au><au>MINORU YAMATO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RESIN PARTICLE, MEDICAL MATERIAL AND PHARMACEUTICAL PREPARATION CONTAINING SAID RESIN PARTICLE</title><date>1997-10-31</date><risdate>1997</risdate><abstract>A resin particle is provided which comprises an ethylene vinyl alcohol copolymer and 5 to 90 percent by weight of cilostazol incorporated therein, and has a particle size of not greater than 2,000 'mu'm. The resin particle, upon being administered orally, allows the concentration of cilostazol in blood to be kept constant over an extended period of time and, therefore, remarkably alleviates side effects such as pain and headache which may otherwise be caused by rapid release of cilostazol into a body. Se provee una partícula de resina que comprende un copolímero de etileno y alcohol vinílico y de 5 a 90% en peso de cilostazol incorporado en el mismo, y tiene un tamaño de partícula no mayor de 2,000 æm; la partícula de resina, al ser administrada oralmente, permite que la concentracion de cilostazol en sangre se mantenga constante durante un periodo prolongado y por lo tanto alivia notablemente los efectos secundarios tales como cefalgia y fuerte malestar, que pueden ocasionarse de otra manera por la liberacion rápida de cilostazol en el cuerpo.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX9705185A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title RESIN PARTICLE, MEDICAL MATERIAL AND PHARMACEUTICAL PREPARATION CONTAINING SAID RESIN PARTICLE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T17%3A52%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HIROAKI%20YAMAMOTO&rft.date=1997-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX9705185A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true